OpenLB
Open Library of Bioscience
Advanced Search
Science (New York, N.Y.)
10 20, 2023;382 (6668): 251-252.

Probe of Alzheimer's studies finds 'egregious misconduct'.

Charles Piller
Author Information
PMID: 37856608 DOI: 10.1126/science.adl4276

Abstract

Co-developer of biotech's drug couldn't supply original data.

MeSH Term

Humans
Alzheimer Disease
Biotechnology
Spiro Compounds
Scientific Misconduct
United States

Chemicals

Simufilam
Spiro Compounds
News
Article has an altmetric score of 14

Word Cloud

Created with Highcharts 10.0.0Co-developerbiotech'sdrugsupplyoriginaldataProbeAlzheimer'sstudiesfinds'egregiousmisconduct'

Similar Articles

Cited By